Cantor Fitzgerald research analysts reportedly downgraded their recommendation for Cutera (NASDAQ: CUTR) on Wednesday, sending investors a note in which they stated the company’s rating has been changed from “overweight” to “neutral.” The note also stated that the analysts had downgraded their recommendation for the company.

Many brokerages have voiced their support for CUTR as an investment option. On October 12th, StockNews.com released a research note, which marked the beginning of the website’s coverage of shares of Cutera. They recommended “selling” the stock to prospective buyers. Stephens lowered their price target on shares of Cutera from $80.00 down to $60.00 in a report published on Wednesday, December 28th. Despite this change, they continued to maintain an “overweight” rating on the stock. Three analysts are in favor of buying the stock; one is in favor of keeping the stock, and one is in favor of selling the stock. The stock currently has a rating of “Hold,” which is the recommendation given by the majority of analysts, and the average price target set for the stock is $68.25. These details were gleaned from the website Bloomberg.com. Microdermabrasion Machine Benefits

CUTR began trading on Wednesday under the NASDAQ ticker: CUTR for $29.83.

The stock’s simple moving average over the past 50 days is $44.13, and its simple moving average over the past 200 days is $45.02.

The company’s current market value is $585.12 million, and its price-to-earnings ratio is -7.09. The company also has a beta value of 1.68. The current ratio is 3.73, the quick ratio is 3.16, and the debt-to-equity ratio is the same at 3.16. Over the previous year, the price of Cutera has ranged anywhere from $29.49 to $74.38, with an average price of $74.38.

On the company’s website, which can be accessed through the ticker symbol NASDAQ: CUTR, you can find the most recent quarterly results report announced for Cutera on November 3rd. The medical equipment manufacturer reported earnings per share for the quarter at $0.62, which was $0.38 less than the average estimate of $0.24. Cutera’s return on equity was 225.70%, and the company’s net margin was 31.31%, both significantly lower than the company’s overall profitability. The revenue for the quarter came in at $62.81 million, which is higher than the $62.65 million analysts had anticipated for the same period. According to projections made by stock market analysts, the current financial year is expected to bring Cutera a loss of -2.39 cents per share.

As a result of recent happenings, several large investors have altered the proportion of the company’s stock they currently hold in their portfolios. During the second quarter, Mirador Capital Partners LP expanded its holdings in Cutera by 2.9% by purchasing additional company shares. Mirador Capital Partners LP now has a total of 9,863 holdings in the medical device company, with a market capitalization of $370,000 after purchasing an additional 274 shares during the most recent quarter. The market capitalization of the company is $370,000. During the third quarter, the New York State Common Retirement Fund increased the amount of Cutera stock that it held by 1.3%, bringing the total amount of Cutera stock that it owned to a total of 1.7%. The New York State Common Retirement Fund has a total of 25,235 shares of stock in the medical device company after purchasing an additional 329 shares during the period. This brings the fund’s total number of shares to 25,235. These shares are currently worth $1,150,000 at the current market price. During the second quarter, Prudential Financial Inc. increased the amount of Cutera stock owned by 2.0%, bringing the total to 100%. There are currently 17,625 shares of the medical device company’s stock owned by Prudential Financial Inc. These shares have a value of $708,000. This goal was accomplished by purchasing 340 shares of the company’s stock during the relevant period in question. During the second quarter, the Texas Permanent School Fund increased the amount of Cutera stock owned by 3.1%, bringing the total percentage of Cutera stock to 100%. The Texas Permanent School Fund invested in the company by purchasing an additional 361 shares during the most recent fiscal quarter, bringing its total number of shares purchased to 11,946 and giving it a market valuation of $448,000. Not to mention, during the period covered by the report for the second quarter, Mutual of America Capital Management LLC increased the amount of Cutera stock owned by 17.8%, making this the last and most important point. Since the beginning of the most recent quarter, Mutual of America Capital Management LLC has acquired an additional 420 shares of the medical device company, bringing their total number of shares owned in this sector to 2,775. The current value of these shares on the market is equal to $104,000.

Laser and energy-based aesthetics equipment is sold to practitioners worldwide by Cutera, Inc., a medical device company that conducts research, develops, produces, markets, and provides services for this equipment. These tools have many applications and can be used in many different places. For example, the company’s Secret PRO device, which combines radio frequency (RF) microneedling and fractional CO2 treatment, can accomplish deep dermal remodeling. This is made possible by the combination of these two procedures. In addition to that, it offers the Excel V+ platform for the treatment of vascular and benign pigmented lesions, the truSculpt iD for non-surgical body sculpting, the Secret RF system for tissue coagulation and hemostasis, and the truSculpt flex, which is a bio-electrical muscle stimulation device that can be used on patients of all different fitness levels.

Over the last nine years, Elaine has managed investment portfolio using fundamental analysis and value investing, emphasizing long-term time horizons.

Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.

The Best Stocks , its managers, its employees, affiliates and assigns (collectively “The Company”) do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.

Follow us on Social Media Facebook – YouTube – Twitter

Write for us Finance – Business

Categories Best Stocks to buy now Crypto Dow Jones Today Pre-IPO and Startups Tech stocks Utility Stocks

Data and Tools Quote Target Wealth Converter Dow Jones Today

Best Stocks to Buy Now

clinic salon equipment co2 fractional laser We are a financial media dedicated to providing stock recommendations, news, and real-time stock prices.